午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid

2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid Struktur
2760889-63-0
CAS-Nr.
2760889-63-0
Englisch Name:
2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid
Synonyma:
Glycine, N-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]oxy]acetyl]-;2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid
CBNumber:
CB514304223
Summenformel:
C17H15N3O8
Molgewicht:
389.32
MOL-Datei:
2760889-63-0.mol

2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid Eigenschaften

Siedepunkt:
827.090±65.00 °C(Press: 760.00 Torr)(predicted)
Dichte
1.584±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka
3.233±0.10(predicted)

Sicherheit

2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Alfa Chemistry 		+1-5166625404;
Info@alfa-chemistry.com United States 20405 58
Pharmalego 18321033991
marketing@pharmalego.com China 3220 58
Taizhou Zhongzhi Biotechnology Co., Ltd 13012344321
 3995296515@qq.com China 7996 58
  • 2-(2-[(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl)oxy]acetamido)acetic acid
  • Glycine, N-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-5-yl]oxy]acetyl]-
  • 2760889-63-0
Copyright 2019 ? ChemicalBook. All rights reserved